Related Experiment Video
Updated: May 10, 2026

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
Association of Cardiac Damage and Computed Tomography-Derived Extracellular Volume in Patients Undergoing
Marta Belmonte1, Pasquale Paolisso2, Elayne Kelen de Oliveira3
1Cardiovascular Center Aalst, OLV-Clinic, Aalst, Belgium; Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy; Cardiology Unit, Sant'Andrea University Hospital, Rome, Italy.
Insights
Elevated extracellular volume (ECV) measured by cardiac CT predicts cardiac damage progression and limits functional recovery after transcatheter aortic valve implantation (TAVI) in severe aortic stenosis patients.
Area of Science:
- Cardiology
- Radiology
- Medical Imaging
Background:
- Severe aortic stenosis (AS) poses risks, with extravalvular cardiac damage (EVCD) and extracellular volume (ECV) impacting outcomes after transcatheter aortic valve implantation (TAVI).
- Assessing ECV via cardiac computed tomography (CT) is crucial for understanding EVCD dynamics.
- This study investigates the link between CT-derived ECV and EVCD before and after TAVI.
Purpose of the Study:
- To evaluate the association of CT-derived ECV with EVCD progression and severity post-TAVI.
- To determine ECV's impact on left ventricular reverse remodeling and functional status at 3-month follow-up.
- To identify predictors of EVCD progression and functional improvement after TAVI.
Main Methods:
- A prospective study involving 73 patients undergoing TAVI, with baseline and follow-up CT and echocardiography.
- ECV cutoff values were determined to predict EVCD progression and advanced stages.
- Logistic regression analysis identified predictors of EVCD progression and functional outcomes.
Main Results:
- A significant portion (34.2%) of patients experienced EVCD progression at 3 months.
- ECV ≥ 32% effectively predicted EVCD progression and advanced stages (ROC AUC 0.66, P < 0.001).
- High ECV patients showed more advanced EVCD (P=0.011) and greater progression (P=0.012). Low ECV patients had better LV reverse remodeling (P=0.004) and NYHA functional class improvement (P=0.020 at 3 months, P=0.001 at 6 months).
Conclusions:
- Elevated CT-derived ECV is linked to increased EVCD progression after TAVI.
- High ECV independently predicts EVCD progression, advanced stages, and lack of functional improvement post-TAVI.
- ECV measurement offers valuable prognostic information for TAVI patients.
Background:
Extravalvular cardiac damage (EVCD) and extracellular volume (ECV) are key determinants of poor outcomes in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI). We aimed to assess the association of ECV derived by means of cardiac computed tomography (CT) with EVCD before and after TAVI, its impact on left ventricular reverse remodelling, and functional improvements at 3-month follow-up in patients with severe AS undergoing TAVI.
Methods:
This was a prospective study of 73 consecutive patients undergoing TAVI, with CT-derived ECV assessment and baseline and follow-up echocardiographic evaluation of EVCD. After identifying the best ECV cutoff for predicting EVCD progression and advanced EVCD (stages 3-4) at follow-up according to the Youden index, patients were divided into low (n = 39) and high (n = 34) ECV groups. Predictors of EVCD progression, advanced EVCD, and functional improvements at follow-up were identified by means of logistic regression analysis.
Results:
At 3-month follow-up, 34.2% of patients showed EVCD progression. ECV ≥ 32% accurately predicted EVCD progression and stages 3-4 (area under the receiver operating characteristic curve 0.66, P < 0.001). At follow-up, patients with high ECV were more frequently in stages 3-4 (P = 0.011) and had a 50% progression rate (P = 0.012). Conversely, patients with low ECV exhibited greater LV reverse remodelling (P = 0.004) and improvement in New York Heart Association (NYHA) functional class at both 3-month (P = 0.020) and 6-month (P = 0.001) follow-ups compared with patients with high ECV. High ECV emerged as an independent predictor of EVCD progression (odds ratio [OR] 4.34, 95% CI 1.36-13.78, P = 0.013), stages 3-4 (OR 5.71, 95% CI 1.77-18.42, P = 0.004) and lack of improvement in NYHA functional class (OR 3.22, 95% CI 1.14-9.09, P = 0.027) at 3-month follow-up.
Conclusions:
Elevated CT-derived ECV was associated with EVCD progression and reduced functional improvement after TAVI.
More Related Videos
09:32Time-Resolved, Dynamic Computed Tomography Angiography for Characterization of Aortic Endoleaks and Treatment Guidance via 2D-3D Fusion-Imaging
Published on: December 9, 2021
09:57Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Aortic Regurgitation II: Clinical Features and Diagnostic Tests